Dandona P, Coumar A, Gill D S, Bell J, Thomas M
Department of Chemical Pathology and Human Metabolism, Royal Free Hospital and School of Medicine, London, UK.
Clin Endocrinol (Oxf). 1988 Oct;29(4):437-41. doi: 10.1111/j.1365-2265.1988.tb02893.x.
To test whether the administration of sodium fluoride in vivo results in an increase in osteocalcin concentration, we administered sodium fluoride to seven healthy male subjects for a period of 3 weeks. Fasting calcium, phosphate, alkaline phosphatase, 25-hydroxyvitamin D, parathyroid hormone and osteocalcin were measured prior to, during and 6 weeks after fluoride administration. Plasma calcium, phosphate and alkaline phosphatase and serum 25-hydroxyvitamin D and parathyroid hormone concentrations did not alter. Serum osteocalcin concentrations increased following fluoride administration, and the mean osteocalcin concentration at 3 weeks was significantly higher than the pretreatment mean. Plasma urea and creatinine concentrations did not alter. Six weeks after the cessation of fluoride treatment, the mean serum osteocalcin concentration had returned to the pretreatment baseline. We conclude that fluoride administration in normal subjects over a short period increases serum osteocalcin concentration and probably stimulates osteoblastic activity.
为了测试体内给予氟化钠是否会导致骨钙素浓度升高,我们对7名健康男性受试者给予氟化钠,为期3周。在给予氟化物之前、期间和之后6周测量空腹血钙、血磷、碱性磷酸酶、25-羟基维生素D、甲状旁腺激素和骨钙素。血浆钙、磷和碱性磷酸酶以及血清25-羟基维生素D和甲状旁腺激素浓度未发生改变。给予氟化物后血清骨钙素浓度升高,3周时的平均骨钙素浓度显著高于治疗前的平均值。血浆尿素和肌酐浓度未发生改变。停止氟化物治疗6周后,血清骨钙素平均浓度已恢复至治疗前基线水平。我们得出结论,短期内对正常受试者给予氟化物会增加血清骨钙素浓度,并可能刺激成骨细胞活性。